135 related articles for article (PubMed ID: 37172933)
1. The contribution of PET/CT to the differentiation of benign and malignant pleural effusion in patients with ovarian carcinoma.
Budak A; Yanarateş A; Budak E
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2023; 42(6):353-358. PubMed ID: 37172933
[TBL] [Abstract][Full Text] [Related]
2. Can PET/CT be used more effectively in pleural effusion evaluation?
Simsek FS; Yuksel D; Yaylali O; Aslan HS; Kılıçarslan E; Bir F; Arslan M; Can FE; Ugurlu E
Jpn J Radiol; 2021 Dec; 39(12):1186-1194. PubMed ID: 34165683
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of the PET-CT score for diagnosis of malignant pleural effusion.
Yang MF; Tong ZH; Wang Z; Zhang YY; Xu LL; Wang XJ; Li W; Wu XZ; Wang W; Zhang YH; Jiang T; Shi HZ
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1457-1467. PubMed ID: 30903197
[TBL] [Abstract][Full Text] [Related]
4. A PET-CT score for discriminating malignant from benign pleural effusions.
Simó M; Persiva O; Sánchez L; Montoro B; Vázquez A; Sansano I; Alemán C
Med Clin (Barc); 2023 Nov; 161(10):422-428. PubMed ID: 37487808
[TBL] [Abstract][Full Text] [Related]
5. [Value of PET/MRI in the diagnosis of malignant pleural effusion in comparison with PET/CT].
Peng WB; Sun X; Zhou M; Wei XS; Wu XZ; Ruan WW; Shi HZ; Lan XL; Zhou Q
Zhonghua Yi Xue Za Zhi; 2021 Aug; 101(30):2363-2369. PubMed ID: 34404128
[No Abstract] [Full Text] [Related]
6. Diagnostic Value of Six Tumor Markers for Malignant Pleural Effusion in 1,230 Patients: A Single-Center Retrospective Study.
Fan X; Liu Y; Liang Z; Wang S; Yang J; Wu A
Pathol Oncol Res; 2022; 28():1610280. PubMed ID: 35515016
[No Abstract] [Full Text] [Related]
7. Validity of procalcitonin and C-reactive protein measurement when differentiating between benign and malignant pleural effusion.
Botana-Rial M; Casado-Rey P; Leiro-Fernández V; Andrade-Olivié M; Represas-Represas C; Fernández-Villar A
Clin Lab; 2011; 57(5-6):373-8. PubMed ID: 21755828
[TBL] [Abstract][Full Text] [Related]
8. The utility of multi-detector computed tomography in the diagnosis of malignant pleural effusion in the patients with ovarian cancer.
Kim KW; Choi HJ; Kang S; Park SY; Jung DC; Cho JY; Cho KS; Kim SH
Eur J Radiol; 2010 Aug; 75(2):230-5. PubMed ID: 19481402
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of F-18 FDG PET/CT for malignant pleural effusion in non-small cell lung cancer patients.
Kim BS; Kim IJ; Kim SJ; Pak K; Kim K
Onkologie; 2011; 34(6):298-303. PubMed ID: 21625182
[TBL] [Abstract][Full Text] [Related]
10. Differences in
Xie T; Wang Q; Gao J; He K; Yu J
Ann Clin Lab Sci; 2024 Mar; 54(2):201-210. PubMed ID: 38802158
[TBL] [Abstract][Full Text] [Related]
11. Differentiating malignant and benign pleural effusion in patients with lung cancer: an
Zhang W; Liu Z; Duan X; Li Y; Shen C; Guo Y; Yang J
Front Oncol; 2023; 13():1192870. PubMed ID: 37456249
[TBL] [Abstract][Full Text] [Related]
12. FDG PET of pleural effusions in patients with non-small cell lung cancer.
Erasmus JJ; McAdams HP; Rossi SE; Goodman PC; Coleman RE; Patz EF
AJR Am J Roentgenol; 2000 Jul; 175(1):245-9. PubMed ID: 10882281
[TBL] [Abstract][Full Text] [Related]
13. [Clinical role of F-18 FDG PET/CT in differentiating malignant and benign pleural effusion in patients with lung cancer].
Liao R; Yang X; Wang S; Zhou Q; Nie Q; Zhong W; Dong S; Wu Y
Zhongguo Fei Ai Za Zhi; 2012 Nov; 15(11):652-5. PubMed ID: 23164351
[TBL] [Abstract][Full Text] [Related]
14. The Role of 18F-FDG PET/CT Integrated Imaging in Distinguishing Malignant from Benign Pleural Effusion.
Sun Y; Yu H; Ma J; Lu P
PLoS One; 2016; 11(8):e0161764. PubMed ID: 27560933
[TBL] [Abstract][Full Text] [Related]
15. Clinical role of F-18 fluorodeoxyglucose positron emission tomography imaging in patients with lung cancer and suspected malignant pleural effusion.
Gupta NC; Rogers JS; Graeber GM; Gregory JL; Waheed U; Mullet D; Atkins M
Chest; 2002 Dec; 122(6):1918-24. PubMed ID: 12475827
[TBL] [Abstract][Full Text] [Related]
16. Correlation of
Mayoral M; Paredes P; Saco A; Fusté P; Perlaza P; Tapias A; Fernandez-Martinez A; Vidal L; Ordi J; Pavia J; Martinez-Roman S; Lomeña F
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(2):80-86. PubMed ID: 28869177
[TBL] [Abstract][Full Text] [Related]
17. [The value of B7-H4 and carcinoembryonic antigen in diagnosing the benign and malignant pleural effusion].
Wei F; Wei Y; Li LF; Li GL; Wang GJ
Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):524-527. PubMed ID: 28728299
[No Abstract] [Full Text] [Related]
18. Differentiation of malignant from benign pleural effusions based on artificial intelligence.
Wang S; Tan X; Li P; Fan Q; Xia H; Tian S; Pan F; Zhan N; Yu R; Zhang L; Duan Y; Xu J; Ma Y; Chen W; Li Y; Zhao Z; Liu C; Bao Q; Yang L; Jin Y
Thorax; 2023 Apr; 78(4):376-382. PubMed ID: 36180066
[TBL] [Abstract][Full Text] [Related]
19. Predicting Malignant and Paramalignant Pleural Effusions by Combining Clinical, Radiological and Pleural Fluid Analytical Parameters.
Herrera Lara S; Fernández-Fabrellas E; Juan Samper G; Marco Buades J; Andreu Lapiedra R; Pinilla Moreno A; Morales Suárez-Varela M
Lung; 2017 Oct; 195(5):653-660. PubMed ID: 28656381
[TBL] [Abstract][Full Text] [Related]
20. Different characteristics of pleural abnormalities on computed tomography between tuberculous and malignant pleural effusions.
Lee J; Park J; Park JE; Lee YH; Choi SH; Seo H; Yoo SS; Lee SY; Cha SI; Park JY; Lim JK; Kim CH
Am J Med Sci; 2023 Jul; 366(1):57-63. PubMed ID: 37105238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]